Abstract Details
Faye McKenna
(UCSF)
PRESENTER |
No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Shubir Dutt | Mr. Dutt has nothing to disclose. |
Jon Elofson | No disclosure on file |
John Kornak | No disclosure on file |
Bruce L. Miller, MD, FAAN (University of California, San Francisco) | Dr. Miller has nothing to disclose. |
Howard J. Rosen, MD (UCSF) | Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities. |